Dr. Renee Wegrzyn joined DARPA as a Program Manager in 2016. She is interested in applying the tools of synthetic biology to support biosecurity and outpace infectious disease. Prior to joining DARPA as a PM, Dr. Wegrzyn was a Senior Lead Biotechnologist at Booz Allen Hamilton, where she led a team that provided scientific and strategic support in the areas of biodefense, biosecurity, disruptive technologies, emerging infectious disease, neuromodulation, and synthetic biology to DARPA and other federal and private institutions.